Laboratory-based surveillance in Latin America: attributes and limitations in evaluation of pneumococcal vaccine impact

References

• Murray J, Cohen AL. Infectious disease surveillance. Int Encycl Public Health. 2017;4:222–29. doi:10.1016/B978-0-12-803678-5.00517-8.
   Google Scholar
• Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA. 1983;249:1181–85. doi:10.1001/jama.1983.03330330059036.
   PubMed Web of Science ®Google Scholar
• Pan-American Health Organization (PAHO). XVII meeting of the technical advisory group on vaccine-preventable diseases. 2006. https://www.paho.org/en/documents/protecting-health-americas-moving-child-family-immunization .
   Google Scholar
• Pan-American Health Organization (PAHO). Surveillance of bacterial pneumonia and meningitis in children aged under 5 years field guide. 2010. https://iris.paho.org/handle/10665.2/49153 .
   Google Scholar
• Agudelo CI, Castaneda-Orjuela C, Brandileone MCC, Echaniz-Aviles G, Almeida SCG, Carnalla-Barajas MN, Regueira M, Fossati S, Alarcon P, Araya P, et al. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study. Lancet Infect Dis. 2021;21:405–17. doi:10.1016/S1473-3099(20)30489-8.
   PubMed Web of Science ®Google Scholar
• Institutional Repository for Information Sharing (IRIS). Informe regional de SIREVA II, 2017. 2017. https://iris.paho.org/handle/10665.2/53136 .
   Google Scholar
• de Oliveira LH, Trumbo SP, Ruiz Matus C, Sanwogou NJ, Toscano CM. Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned. Expert Rev Vaccines. 2016;15:1295–304. doi:10.1586/14760584.2016.1166961.
   PubMed Web of Science ®Google Scholar
• Gentile A, Bakir J, Firpo V, Casanueva EV, Ensinck G, Lopez Papucci S, Lucion MF, Abate H, Cancellara A, Molina F, et al. PCV13 vaccination impact: a multicenter study of pneumonia in 10 pediatric hospitals in Argentina. PLoS One. 2018;13:e0199989. doi:10.1371/journal.pone.0199989.
   PubMed Web of Science ®Google Scholar
• Camacho Moreno G, Imbachi LF, Leal AL, Moreno VM, Patino JA, Gutierrez IF, Beltran S, Alvarez-Olmos MI, Marino C, Barrero R, et al. Emergence of streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogota, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10. Hum Vaccin Immunother. 2020;16:2300–06. doi:10.1080/21645515.2019.1710411.
   PubMed Web of Science ®Google Scholar
• Shioda K, Toscano CM, Valenzuela MT, Huarcaya WV, Warren JL, Weinberger DM, de Oliveira LH. Impact of pneumococcal conjugate vaccine uptake on childhood pneumonia mortality across income levels in Brazil, Colombia, and Peru. Gates Open Res. 2020;4:136. doi:10.12688/gatesopenres.13187.1.
   PubMedGoogle Scholar
• Diaz J, Terrazas S, Bierrenbach AL, Toscano CM, Alencar GP, Alvarez A, Valenzuela MT, Andrus J, del Aguila R, Hormazabal JC, et al. Effectiveness of the 10-valent pneumococcal conjugate vaccine (PCV-10) in children in chile: a nested case-control study using nationwide pneumonia morbidity and mortality surveillance data. PLoS One. 2016;11:e0153141. doi:10.1371/journal.pone.0153141.
   PubMed Web of Science ®Google Scholar
• Jimbo Sotomayor R, Toscano CM, Sanchez Choez X, Vilema Ortiz M, Rivas Condo J, Ghisays G, Haneuse S, Weinberger DM, McGee G, de Oliveira LH. Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: time series analyses. Vaccine. 2020;38:7033–39. doi:10.1016/j.vaccine.2020.09.032.
   PubMed Web of Science ®Google Scholar
• Echaniz-Aviles G, Garza-Gonzalez E, Roman-Mancha AL, Morfin-Otero R, Rodriguez-Noriega E, Ayala-Gaytan JJ, Guajardo-Lara CE, Soto-Nogueron A, Carnalla-Barajas MN, Camacho-Ortiz A. Clinical and microbiological characteristics of community-acquired pneumonia associated with streptococcus pneumoniae in adult patients in Mexico. Rev Argent Microbiol. 2019;51:234–40. doi:10.1016/j.ram.2018.10.002.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. doi:10.1016/S0140-6736(09)61204-6.
   PubMed Web of Science ®Google Scholar
• United Nations Department of Economic and Social Affairs Population Division. World population prospects: the 2019 revision. 2019. https://population.un.org/wpp/Download/Standard/Population/ .
   Google Scholar
• Naucler P, Galanis I, Morfeldt E, Darenberg J, Ortqvist A, Henriques-Normark B. Comparison of the impact of pneumococcal conjugate vaccine 10 or pneumococcal conjugate vaccine 13 on invasive pneumococcal disease in equivalent populations. Clin Infect Dis. 2017;65:1780–89. doi:10.1093/cid/cix685.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Measuring impact of streptococcus pneumoniae and haemophilus influenzae type b conjugate vaccination. 2012. https://apps.who.int/iris/bitstream/handle/10665/75835/WHO_IVB_12.08_eng.pdf;jsessionid=D992DBF31243DB3967C18C75B06D4903?sequence=1 .
   Google Scholar
• United States General Accounting Office. Challenges in improving infectious disease surveillance systems. 2001.
   Google Scholar
• John J. The remaining challenges to laboratory-based surveillance of invasive pneumococcal disease. Indian Pediatr. 2015;52:199–200. doi:10.1007/s13312-015-0606-1.
   PubMed Web of Science ®Google Scholar
• Pezzotti P, Bellino S, Riccardo F, Lucaroni F, Cerquetti M, Pantosti A, Rezza G, Stefanelli P. Vaccine preventable invasive bacterial diseases in Italy: a comparison between the national surveillance system and recorded hospitalizations, 2007-2016. Vaccine. 2019;37:41–48. doi:10.1016/j.vaccine.2018.11.047.
   PubMed Web of Science ®Google Scholar